Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05910801 |
Title | Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (V-MIND) |
Acronym | V-MIND |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Academic and Community Cancer Research United |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic in Rochester | RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
M D Anderson Cancer Center | NOT_YET_RECRUITING | Houston | Texas | 77030 | United States | Details |